Panel Discussion: Optimizing Clinical Development Partnerships Using Genomic Data, and Advanced-analytics
Moderator: Michael Yasiejko MBA, Executive Vice President and General Manager, Tempus Labs
Panelists: Josh Bell PhD, Director, Computational Biology, Tempus Labs; Pavan Kumar, PhD, Vice President, Translation, Kronos Bio; Charles Lin, PhD, Senior Vice President, Biology, Kronos Bio
As one of the leaders pioneering real-world data, Tempus’ robust clinico-genomic database can be used in tandem with trial sequencing data to build a biomarker strategy and compare trial data to real-world data throughout the trial. Tempus’ sequencing data covers DNA tumor/normal, RNA transcriptome, and key immunotherapy metrics, allowing for a more holistic view to stratify likely responders and refine clinical biomarkers.
During this panel discussion, Tempus and Kronos Bio representatives will discuss how they have been using genomics, and advanced analytics to help advance biomarker discovery and oncology clinical development programs.